Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android



  • Any uterine bleeding in a postmenopausal woman (12 months or more following cessation of menstrual cycles) is abnormal and should be evaluated.

  • Transvaginal ultrasound measurement of the endometrium is an important tool in evaluating the cause of postmenopausal bleeding.


Menopause is defined as 1 year without menstrual bleeding. The most common causes of postmenopausal bleeding are endometrial atrophy, endometrial proliferation or hyperplasia, endometrial or cervical cancer, and administration of estrogens without or with added progestin. Other causes include atrophic vaginitis, trauma, endometrial polyps, abrasion of the cervix associated with prolapse of the uterus, and blood dyscrasias.


The vulva and vagina should be inspected for areas of bleeding, ulcers, or neoplasms. Cervical cytology should be obtained, if indicated. Transvaginal sonography should be used to measure endometrial thickness. An endometrial stripe measurement of 4 mm or less indicates a low likelihood of hyperplasia or endometrial cancer. If the endometrial thickness is greater than 4 mm, endometrial sampling is indicated. If there is focal thickening of the endometrium on ultrasound or persistent bleeding despite negative results on endometrial biopsy, guided sampling with hysteroscopy is more appropriate than random endometrial sampling.


Management options for endometrial hyperplasia without atypia include surveillance, oral contraceptives, or progestin therapy. Surveillance may be used if the risk of occult cancer or progression to cancer is low and the inciting factor (eg, anovulation) has been eliminated. Therapy may include taking cyclic or continuous progestin therapy (medroxyprogesterone acetate, 10–20 mg/day orally, or norethindrone acetate, 15 mg/day orally) or using a hormonal IUD. Repeat sampling should be performed if symptoms recur. Hysterectomy is the preferred treatment for endometrial hyperplasia with atypia (also called endometrial intraepithelial neoplasia) or carcinoma of the endometrium. In some patients with endometrial hyperplasia with atypia, progestin therapy with scheduled repeat endometrial sampling may be an alternative to hysterectomy. Patients who elect this approach include those who desire future childbearing or those who are not candidates for surgery.


  • Expertise in performing ultrasonography is required.

  • Endometrial hyperplasia with atypia is present.

  • Hysteroscopy is indicated.

Bar-On  S  et al. Is outpatient hysteroscopy accurate for the diagnosis of endometrial pathology among perimenopausal and postmenopausal women? Menopause. 2018;25:160.
[PubMed: 28763396]  
Khafaga  A  et al. Abnormal uterine bleeding. Obstet Gynecol Clin North Am. 2019;46:595.
[PubMed: 31677744]  
Saccardi  C  et al. Endometrial cancer risk prediction according to indication of diagnostic hysteroscopy in post-menopausal women. Diagnostics (Basel). 2020;10:257.
[PubMed: 32349386]

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.